1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
2019) In Clinical cancer research : an official journal of the American Association for Cancer Research 25(23). p.7139-7150(
- Contribution to journal › Article
-
Mark
The circular RNome of primary breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
(
- Contribution to journal › Article
- 2016
-
Mark
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
(
- Contribution to journal › Article
-
Mark
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
(
- Contribution to journal › Article
-
Mark
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
(
- Contribution to journal › Article
-
Mark
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
(
- Contribution to journal › Article
- 2015
-
Mark
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.
(
- Contribution to journal › Article
-
Mark
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
(
- Contribution to journal › Article